CHEMTURA CORP's ticker is CHMT and the CUSIP is 163893209. A total of 177 filers reported holding CHEMTURA CORP in Q2 2014. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,839,000 | +0.6% | 85,000 | 0.0% | 0.28% | -0.7% |
| Q4 2016 | $2,822,000 | -22.9% | 85,000 | -23.8% | 0.28% | -11.8% |
| Q3 2016 | $3,658,000 | +24.4% | 111,500 | 0.0% | 0.32% | +20.7% |
| Q2 2016 | $2,941,000 | -0.1% | 111,500 | 0.0% | 0.27% | -2.2% |
| Q1 2016 | $2,944,000 | -3.2% | 111,500 | 0.0% | 0.27% | +0.4% |
| Q4 2015 | $3,041,000 | -4.7% | 111,500 | 0.0% | 0.27% | +12.0% |
| Q3 2015 | $3,191,000 | +1.1% | 111,500 | 0.0% | 0.24% | +12.0% |
| Q2 2015 | $3,157,000 | +1.5% | 111,500 | -2.2% | 0.22% | +1.4% |
| Q1 2015 | $3,111,000 | +9.7% | 114,000 | -0.6% | 0.21% | +15.1% |
| Q4 2014 | $2,837,000 | +10.6% | 114,700 | +4.3% | 0.18% | +0.5% |
| Q3 2014 | $2,566,000 | -10.7% | 110,000 | 0.0% | 0.18% | -3.2% |
| Q2 2014 | $2,874,000 | +34.8% | 110,000 | +30.5% | 0.19% | +31.9% |
| Q1 2014 | $2,132,000 | -9.4% | 84,300 | 0.0% | 0.14% | -13.3% |
| Q4 2013 | $2,354,000 | +57.6% | 84,300 | +29.7% | 0.17% | +43.1% |
| Q3 2013 | $1,494,000 | +13.2% | 65,000 | 0.0% | 0.12% | +0.9% |
| Q2 2013 | $1,320,000 | – | 65,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CYRUS CAPITAL PARTNERS, L.P. | 2,089,464 | $48,747,000 | 6.50% |
| RESTRUCTURING CAPITAL ASSOCIATES LP | 338,080 | $7,887,000 | 5.78% |
| Paradice Investment Management LLC | 835,850 | $19,500,000 | 5.07% |
| ROCKSHELTER CAPITAL MANAGEMENT LLC | 782,320 | $18,252,000 | 4.89% |
| Sandhill Capital Partners LLC | 405,261 | $9,455,000 | 3.37% |
| Clearline Capital LP | 880,639 | $20,545,000 | 3.31% |
| WS MANAGEMENT LLLP | 4,338,935 | $101,227,000 | 3.25% |
| Corsair Capital Management | 2,250,976 | $52,516,000 | 2.70% |
| LionEye Capital Management LLC | 1,400,000 | $32,662,000 | 1.79% |
| Tahithromos, L.L.C. | 277,999 | $6,486,000 | 1.68% |